Trials / Unknown
UnknownNCT04890197
Tahini and Dermatitis in Breast Cancer
The Effects of Tahini Consumption on Radiotherapy Induced Dermatitis in Breast Cancer - A Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to investigate the effect of tahini on acute radiation dermatitis in breast cancer (BC) patients undergoing radiotherapy (RT). 50 eligible BC patients will randomly assign to consume tahini 48 gr per day during and 1 week after RT or with no intervention (control group). The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | tahini | 48 grams tahini |
| OTHER | control | no intervention |
Timeline
- Start date
- 2021-05-08
- Primary completion
- 2021-07-01
- Completion
- 2021-07-15
- First posted
- 2021-05-18
- Last updated
- 2021-05-18
Source: ClinicalTrials.gov record NCT04890197. Inclusion in this directory is not an endorsement.